Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-11,186
Closed -$560K 616
2025
Q4
$560K Buy
11,186
+1,495
+15% +$71.9K 0.03% 328
2025
Q3
$476K Buy
9,691
+4
+0% +$205 0.03% 322
2025
Q2
$501K Hold
9,687
0.05% 281
2025
Q1
$453K Hold
9,687
0.03% 394
2024
Q4
$496K Hold
9,687
0.03% 330
2024
Q3
$431K Sell
9,687
-2,132
-18% -$93.2K 0.03% 374
2024
Q2
$475K Hold
11,819
0.04% 325
2024
Q1
$473K Hold
11,819
0.04% 335
2023
Q4
$445K Sell
11,819
-16
-0.1% -$489 0.04% 335
2023
Q3
$329K Buy
11,835
+16
+0.1% +$501 0.03% 376
2023
Q2
$358K Hold
11,819
0.05% 330
2023
Q1
$364K Sell
11,819
-2
-0% -$76 0.06% 278
2022
Q4
$444K Sell
11,821
-3
-0% -$119 0.08% 230
2022
Q3
$444K Hold
11,824
0.11% 182
2022
Q2
$426K Hold
11,824
0.09% 202
2022
Q1
$579K Sell
11,824
-1,609
-12% -$81.5K 0.12% 161
2021
Q4
$643K Buy
13,433
+5,622
+72% +$266K 0.14% 149
2021
Q3
$343K Buy
+7,811
New +$330K 0.09% 215
2020
Q3
Sell
-11
Closed 914
2020
Q2
$0 Hold
11
﹤0.01% 1180
2020
Q1
$0 Hold
11
﹤0.01% 1142
2019
Q4
$0 Buy
+11
New +$404 ﹤0.01% 1064

Other funds holding SNV

Procyon Advisors's SNV Position: Q1 2026 in Review

Procyon Advisors sold out of Synovus (SNV) in Q1 2026, closing a stake of 11,186 shares — an estimated $560K sold.

Procyon Advisors first reported a position in SNV in Q4 2019 and held it in 21 quarters. The position peaked at $643K in Q4 2021. 1 fund tracked by Wall St. Rank holds SNV as of Q1 2026.

  • Procyon Advisors reported no remaining Synovus position as of Q1 2026 after selling out during the quarter.
  • Procyon Advisors sold 11,186 Synovus shares in Q1 2026, an estimated $560K.
  • Procyon Advisors first reported a position in Synovus in Q4 2019 and held it in 21 quarters.
  • Procyon Advisors's Synovus position peaked at $643K in Q4 2021.
  • 1 fund tracked by Wall St. Rank held Synovus as of Q1 2026.

Based on Procyon Advisors's 13F filing for Q1 2026, filed 4 May 2026.